Case studies

Fluoscore

All

Oncology

Liver + 2 Cancer types

DMPK Tox

+

Irinotecan: Liver-dependent efficacy on colon carcinoma, hepatotoxicity, and selectivity (colon cancer vs breast cancer)

Fluoscore

All

Oncology

Liver + Breast cancer

DMPK

+

Tamoxifen: Liver-dependent efficacy on breast adenocarcinoma

Fluoselect

All

Oncology

6 Cancer Types

Selectivity

+

4-hydroxytamoxifen: selective efficacy on a 6-tissue co-culture

Fluoselect

All

Oncology

Two Cancer Types

Selectivity

+

Trastuzumab: binding selectivity in a 2-tissue co-culture

Fluoselect

All

Oncology

6 Cancer Types

Selectivity

+

4-hydroxytamoxifen: selective efficacy on a 6-tissue co-culture

Fluoselect

All

Oncology

Two Cancer Types

Selectivity

+

Trastuzumab: binding selectivity in a 2-tissue co-culture

Fluoscore

All

Oncology

Liver + 2 Cancer types

DMPK Tox

+

Irinotecan: Liver-dependent efficacy on colon carcinoma, hepatotoxicity, and selectivity (colon cancer vs breast cancer)

Fluoscore

All

Oncology

Liver + Breast cancer

DMPK

+

Tamoxifen: Liver-dependent efficacy on breast adenocarcinoma

No items found.

partnership models

Predictive biology

From 3D tissues to integrated systems for better drug discovery decisions.

Your submission has been received

Oops! Something went wrong while submitting the form.

starts today